EH heads into Thursday's Q1 earnings call with the most interesting tension in the stock unchanged: short sellers have stopped moving, borrow is fully locked, and the options market is still dominated by call buyers who have not given up on the trade.
The short position tells a story of conviction rather than drift. SI is 9.5% of free float — but that headline figure understates the intensity of the current setup. The previous article noted that SI had already compressed from a peak near 14.9% in early April down to the 13.5% range, and the ORTEX combined estimate now reflects 9.5% of free float after accounting for the latest float data. What matters is the stasis: over the past two weeks, the short book has barely moved. Bears who survived the April unwind are sitting on their hands ahead of the print. Days to cover on the official FINRA figure is 12.2 — meaning at average volume, it would take over two weeks to cover the position. That is not a crowd on its way out.
The borrow market is about as tight as it gets. Availability has been pinned in the 10–11% range all week — roughly one share available for every nine already lent out. The 52-week minimum availability was near zero, hit in late April, and conditions today are materially easier than that episode, but still firmly in the very tight zone. Cost to borrow has risen 8.5% over the past week to 2.1%, after dropping sharply from highs above 4% in early May. The lending pool is not getting meaningfully easier to access. Anyone wanting to add to a short position this week is working with a constrained supply.
Options positioning remains a sharp contrast to the short side. The put/call ratio is running at 0.042 — extraordinarily call-heavy, and only modestly above its 20-day average of 0.035. The 52-week high on the PCR was 1.02, meaning at some point in the past year traders were buying almost as many puts as calls. Right now, calls outnumber puts by roughly 24 to one. That is not defensive positioning. The options book and the short book are sending conflicting signals: one says the stock goes up after earnings, the other says it doesn't.
The Street backdrop offers little resolution. Analyst data has a degree of staleness here — the most recent action on record is JP Morgan's downgrade to Neutral with a $13 target from November 2025. Prior to that, initiations from BofA, Jefferies, Deutsche Bank, Morgan Stanley, and UBS through 2024–2025 came in with Buy or Overweight ratings and targets ranging from $20 to $30. A mean price target of $129 appears in the data but is clearly inconsistent with the current price of $9.51 and the range of recent analyst targets — this figure should be treated as unreliable. What the analyst record does show is a stock that attracted significant coverage interest in 2024–2025, followed by at least one meaningful step-down in conviction at JP Morgan. Factor scores add nuance: EPS momentum over 30 days ranks in the 92nd percentile and forward EPS growth is in the 95th percentile of the universe, suggesting the fundamental picture on earnings estimates is improving. But the short score sits at 81, ranking in the bottom 1% of the universe on that dimension — a persistently bearish structural signal.
Peers are not making EH's week any easier to read. ACHR gained 10% on the week and EVTL added 12.3%, meaning eVTOL-adjacent names broadly had a constructive week while EH drifted 1% higher with a 2.8% drop on Tuesday alone. SPCE surged 36% on the week, underscoring that speculative aerospace names were catching a serious bid — just not this one.
The print on Thursday morning is the next event that matters. The question is whether Q1 results are strong enough to dislodge a short base that has chosen, explicitly, not to cover on the way down from $10.50 to $9.51 — and whether the call buyers who have been consistent for weeks finally see the catalyst they have been positioned for.
See the live data behind this article on ORTEX.
Open EH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
